These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33745520)

  • 1. Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020.
    Najera H; Ortega-Avila AG
    Am J Prev Med; 2021 Apr; 60(4):471-477. PubMed ID: 33745520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
    Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
    Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 mortality effects of underlying health conditions in India: a modelling study.
    Novosad P; Jain R; Campion A; Asher S
    BMJ Open; 2020 Dec; 10(12):e043165. PubMed ID: 33328263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.
    Parra-Bracamonte GM; Parra-Bracamonte FE; Lopez-Villalobos N; Lara-Rivera AL
    Nephrology (Carlton); 2021 Mar; 26(3):248-251. PubMed ID: 33184959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations and factors associated with mortality from COVID-19 in older adults: Retrospective population-based study with 9807 older Brazilian COVID-19 patients.
    de Souza CD; de Arruda Magalhães AJ; Lima AJ; Nunes DN; de Fátima Machado Soares É; de Castro Silva L; Santos LG; Dos Santos Cardoso VI; Nobre YV; do Carmo RF
    Geriatr Gerontol Int; 2020 Dec; 20(12):1177-1181. PubMed ID: 33111433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico).
    Salinas-Aguirre JE; Sánchez-García C; Rodríguez-Sanchez R; Rodríguez-Muñoz L; Díaz-Castaño A; Bernal-Gómez R
    Rev Clin Esp (Barc); 2022 May; 222(5):288-292. PubMed ID: 34620580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an ecological study.
    Noyola DE; Hermosillo-Arredondo N; Ramírez-Juárez C; Werge-Sánchez A
    J Infect Dev Ctries; 2021 Oct; 15(10):1396-1403. PubMed ID: 34780361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and gastrointestinal symptoms in Mexico, a systematic review: does location matter?
    Pizuorno A; Fierro NA; Copado-Villagrana ED; Herrera-Solís ME; Oskrochi G; Brim H; Ashktorab H
    BMC Infect Dis; 2021 Jun; 21(1):555. PubMed ID: 34116647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current forecast of COVID-19 in Mexico: A Bayesian and machine learning approaches.
    Prieto K
    PLoS One; 2022; 17(1):e0259958. PubMed ID: 35061688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic.
    Padilla-Rivas GR; Delgado-Gallegos JL; Garza-Treviño G; Galan-Huerta KA; G-Buentello Z; Roacho-Pérez JA; Santoyo-Suarez MG; Franco-Villareal H; Leyva-Lopez A; Estrada-Rodriguez AE; Moreno-Cuevas JE; Ramos-Jimenez J; Rivas-Estrilla AM; Garza-Treviño EN; Islas JF
    Front Public Health; 2022; 10():1008565. PubMed ID: 36438268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.
    Pana TA; Bhattacharya S; Gamble DT; Pasdar Z; Szlachetka WA; Perdomo-Lampignano JA; Ewers KD; McLernon DJ; Myint PK
    BMJ Open; 2021 Feb; 11(2):e042034. PubMed ID: 33536319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
    Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
    Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors associated with COVID-19 mortality in Mexico.
    Fomina A; Villa-Romero A; de la Torre GSG; Tirado LL; Wong-Chew RM
    Gac Med Mex; 2024; 160(1):9-16. PubMed ID: 38753557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages.
    Sosa-Rubí SG; Seiglie JA; Chivardi C; Manne-Goehler J; Meigs JB; Wexler DJ; Wirtz VJ; Gómez-Dantés O; Serván-Mori E
    Diabetes Care; 2021 Feb; 44(2):373-380. PubMed ID: 33208487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
    PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated with COVID-19 Mortality in the State of Durango, Mexico.
    González Villarreal SE; Salas Pacheco SM; Vázquez Alaniz F; Betancourt Conde MI; Salas Pacheco JM; Castillo Vazquez KC; Salas Leal AC; Tremillo Maldonado OA; Rojas Contreras JA; Hernández Cosain EI; García Montelongo M
    Int J Med Sci; 2023; 20(8):993-999. PubMed ID: 37484800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.